3 completed. 1 Not applicable, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 1 | Completed 1 |
| Phase 3 | 1 | Completed 1 |
Follow Type 2-diabetes: new trials by email Literature Review of Type 2-diabetes trials Research Report on Type 2-diabetes
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Acute Hyperbaric Oxygen Treatment Increases Hepatic Insulin Sensitivity and Muscle Reactive Oxygen Species in T2D 100% O2 in oxygen chamber, 21% O2 in oxygen chamber - Type 2-diabetes | Not applicable | Completed | German Diabetes Center | 12 | 2020-02-01 | 2023-08-15 |
| Effects of Linagliptin on Renal Endothelium Function in Patients With Type 2 Diabetes. Linagliptin, Placebo - Type 2-diabetes | Phase 3 | Completed | University of Erlangen-Nürnberg Medical School | 65 | 2012-10-01 | 2018-01-12 |
| "Can Soluble-CD163 Discriminate Between Healthy and Unhealthy Obese Individuals?" gastric bypass - Obesity, Insulin Resistance | Completed | University of Aarhus | 31 | 2011-11-01 | 2014-08-13 |
Diabetes Mellitus, Type 2 (3) · Inflammation (1) · Insulin Resistance (1) · Obesity (1)
Diabetes Mellitus (3) · Endocrine System Diseases (3) · Glucose Metabolism Disorders (3) · Metabolic Diseases (3) · Nutritional and Metabolic Diseases (3) · Body Weight (1) · Hyperinsulinism (1) · Nutrition Disorders (1) · Overnutrition (1) · Overweight (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1) · Signs and Symptoms (1)
Gastric Bypass (1) · Linagliptin (1)
German Diabetes Center (1) · University of Aarhus (1) · University of Erlangen-Nürnberg Medical School (1)
Germany (2) · Denmark (1)
Michael Roden, Prof., MD (1) · Roland E Schmieder, MD (1)